Statistically speaking, long term investing is a profitable endeavour. But unfortunately, some companies simply don't...
Here, we discuss some reasons why investing in Theravance (TBPH) stock now may turn out to be a prudent move.
The mean of analysts' price targets for Theravance Bio (TBPH) points to a 90.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.